T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History

T. Rowe Price Investment Management, Inc.

$166 Billion
Q3 2024

A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,031,727 shares of PRCT stock, worth $83.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,031,727

Previous 1,747,089 40.95%

Holding current value

$83.5 Million

Previous $107 Million 22.55%

% of portfolio

0.05%

Previous 0.07%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.31 - $84.99 $40.3 Million - $60.8 Million	-715,362 Reduced 40.95%	1,031,727 $82.7 Million
Q2 2024 Aug 14, 2024	SELL	$45.73 - $69.19 $54.5 Million - $82.5 Million	-1,192,830 Reduced 40.57%	1,747,089 $107 Million
Q1 2024 May 15, 2024	SELL	$40.38 - $50.75 $30.5 Million - $38.3 Million	-755,108 Reduced 20.44%	2,939,919 $145 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $1.12 Million - $1.95 Million	44,928 Added 1.23%	3,695,027 $155 Million
Q3 2023 Nov 14, 2023	BUY	$30.02 - $38.81 $18.7 Million - $24.2 Million	622,432 Added 20.56%	3,650,099 $120 Million
Q2 2023 Aug 14, 2023	BUY	$26.7 - $37.02 $8.07 Million - $11.2 Million	302,378 Added 11.1%	3,027,667 $107 Million
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $730,042 - $1.09 Million	27,404 Added 1.02%	2,725,289 $77.4 Million
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $4.81 Million - $5.81 Million	124,102 Added 4.82%	2,697,885 $112 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $79.5 Million - $130 Million	2,573,783 New	2,573,783 $107 Million

Others Institutions Holding PRCT

# of Institutions

266

Shares Held

38M

Call Options Held

262K

Put Options Held

257K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.61B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Account

T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History